How Far Has AI Come in Liver Fibrosis Staging? A Large-Scale Real-World Dataset and Benchmark

Despite years of methodological progress, how far AI has come in liver fibrosis staging has never been systematically evaluated under the heterogeneous, multi-center conditions that define clinical practice. To address this gap, we introduce LiFS, a large-scale dataset and benchmark derived from the MICCAI 2025 CARE-Liver challenge, comprising 610 patients across multiple centers and scanners with multi-sequence MRI. To the best of our knowledge, LiFS is the first benchmark providing complete gadoxetic acid-enhanced sequences with histopathology-confirmed annotations from diverse real-world scanners. Through systematic evaluation of 9 independently developed methods selected from 96 registered teams against in-cohort radiologist reference results, our findings address how far current AI has progressed toward clinical-level liver fibrosis staging from three complementary perspectives. First, against radiologists, the best AI methods were broadly comparable to the senior radiologist and significantly exceeded the junior radiologist in selected settings, while median AI performance generally approached junior-radiologist levels. Second, from a data perspective, cross-center heterogeneity, label imbalance, and contrast-enhanced sequence variability emerge as the dominant challenges for AI methods. Third, from a technical perspective, methodological design choices, including spatial registration, input dimensionality, multi-modal fusion strategy, and backbone architecture, appear to modulate cross-center robustness, although no single choice alone closes the gap. Overall, LiFS provides a rigorous real-world benchmark for positioning the current state of AI in liver fibrosis staging and for enabling future research on the key challenges that limit clinically reliable deployment.

Combining Radiomics and Machine Learning Approaches for Objective ASD Diagnosis: Verifying White Matter Associations with ASD

Autism Spectrum Disorder is a condition characterized by a typical brain development leading to impairments in social skills, communication abilities, repetitive behaviors, and sensory processing. There have been many studies combining brain MRI images with machine learning algorithms to achieve objective diagnosis of autism, but the correlation between white matter and autism has not been fully utilized. To address this gap, we develop a computer-aided diagnostic model focusing on white matter regions in brain MRI by employing radiomics and machine learning methods. This study introduced a MultiUNet model for segmenting white matter, leveraging the UNet architecture and utilizing manually segmented MRI images as the training data. Subsequently, we extracted white matter features using the Pyradiomics toolkit and applied different machine learning models such as Support Vector Machine, Random Forest, Logistic Regression, and K-Nearest Neighbors to predict autism. The prediction sets all exceeded 80% accuracy. Additionally, we employed Convolutional Neural Network to analyze segmented white matter images, achieving a prediction accuracy of 86.84%. Notably, Support Vector Machine demonstrated the highest prediction accuracy at 89.47%. These findings not only underscore the efficacy of the models but also establish a link between white matter abnormalities and autism. Our study contributes to a comprehensive evaluation of various diagnostic models for autism and introduces a computer-aided diagnostic algorithm for early and objective autism diagnosis based on MRI white matter regions.